GSK plc ADR buy Citigroup Inc.
Start price
13.02.24
/
50%
€38.80
Target price
13.02.25
-
Performance (%)
-11.86%
End price
14.02.25
€34.20
Summary
This prediction ended on 14.02.25 with a price of €34.20. The price of GSK plc ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.86%. Dividends of €1.44 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 4.339% | 4.339% | 68.333% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten